NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 918 filers reported holding NOVARTIS A G in Q3 2015. The put-call ratio across all filers is 1.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $233,000 | -47.8% | 2,950 | -45.4% | 0.02% | -48.6% |
Q2 2016 | $446,000 | +14.1% | 5,400 | 0.0% | 0.04% | +16.7% |
Q1 2016 | $391,000 | -15.9% | 5,400 | 0.0% | 0.03% | -14.3% |
Q4 2015 | $465,000 | -12.8% | 5,400 | -6.9% | 0.04% | -22.2% |
Q3 2015 | $533,000 | -6.5% | 5,800 | 0.0% | 0.04% | +9.8% |
Q2 2015 | $570,000 | -18.9% | 5,800 | -18.7% | 0.04% | -21.2% |
Q1 2015 | $703,000 | -17.5% | 7,132 | -22.4% | 0.05% | -20.0% |
Q4 2014 | $852,000 | -1.4% | 9,192 | +0.1% | 0.06% | -5.8% |
Q3 2014 | $864,000 | +4.0% | 9,182 | 0.0% | 0.07% | +6.2% |
Q2 2014 | $831,000 | +6.4% | 9,182 | 0.0% | 0.06% | +4.8% |
Q1 2014 | $781,000 | +5.8% | 9,182 | 0.0% | 0.06% | +5.1% |
Q4 2013 | $738,000 | -0.7% | 9,182 | -5.2% | 0.06% | -7.8% |
Q3 2013 | $743,000 | +8.5% | 9,682 | 0.0% | 0.06% | +4.9% |
Q2 2013 | $685,000 | – | 9,682 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |